Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
fulvic acid (1 trial)
Influenza, Human (Phase 4)
Pneumonia (Phase 4)
Pneumonia, Pneumococcal (Phase 4)
Trials (1 total)
Trial APIs (2 total)